# Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract

> **NCT03917420** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 10 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Tenofovir 300Mg Oral Tablet
- **DRUG:** Emtricitabine 200 MG

## Key facts

- **NCT ID:** NCT03917420
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-26
- **Primary completion:** 2019-09-04
- **Final completion:** 2019-09-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03917420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03917420, "Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03917420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*